Science Daily -
26 Sep 2026 08:31
Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drugs powerful benefits and inspire more comprehensive treatments for obesity and diabetes.
Share this Article